Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Molecular Pharmaceutics|July 16, 2026
Development of a Long-Acting FAPI Dimer Albb-2FAPI for Diagnosis and Therapy of FAP-Positive TumorsMengqi Shi, Xuejun Wen, Yucen Tao, et al.European Journal of Medicinal Chemistry|July 1, 2020
Medicinal chemistry insights into novel CDC25 inhibitorsYucen Tao, Xia Hao, Xiao Ding, et al.ACS Applied Materials & Interfaces|July 23, 2024
Targeted Radionuclide Therapy in GlioblastomaXiaobin Zhao, Vivianne Jakobsson, Yucen Tao, et al.The Journal of Infectious Diseases|December 8, 2022
The Quinone-Derived Small Molecule M5N32 Is an Effective Anti-Helicobacter pylori Agent Both In Vivo and In VitroLiyuan Wang, Yanbo Yu, Yucen Tao, et al.Bioactive Materials|January 31, 2024
pH/GSH dual responsive nanosystem for nitric oxide generation enhanced type I photodynamic therapyJianhua Zou, Zheng Li, Yang Zhu, et al.Bioorganic Chemistry|August 24, 2021
Discovery of potent and selective Cdc25 phosphatase inhibitors via rapid assembly and in situ screening of Quinonoid-focused librariesYucen Tao, Xia Hao, Lanlan Jing, et al.Journal of Medicinal Chemistry|January 27, 2022
Discovery of Novel Bicyclic Imidazolopyridine-Containing Human Urate Transporter 1 Inhibitors as Hypouricemic Drug Candidates with Improved Efficacy and Favorable DruggabilityTong Zhao, Jian Zhang, Yucen Tao, et al.European Journal of Medicinal Chemistry|August 17, 2021
Discovery, optimization, and target identification of novel coumarin derivatives as HIV-1 reverse transcriptase-associated ribonuclease H inhibitorsDongwei Kang, Çagil Urhan, Fenju Wei, et al.RSC Medicinal Chemistry|July 24, 2023
Design, synthesis, and mechanistic study of 2-piperazineone-bearing peptidomimetics as novel HIV capsid modulatorsXujie Zhang, Lin Sun, Shujing Xu, et al.Acta Pharmaceutica Sinica. B|April 3, 2025
Safety, dosimetry, and efficacy of an optimized long-acting somatostatin analog for peptide receptor radionuclide therapy in metastatic neuroendocrine tumors: From preclinical testing to first-in-human studyWei Guo, Xuejun Wen, Yuhang Chen, et al.Pageof 2